LITEMED

Executive Summary

LITEMED (寶健科技) is a Taiwan-based medical device company with over 30 years of experience in urology and male health. The company designs and manufactures a diversified portfolio including shockwave lithotripsy systems, extracorporeal shockwave therapy, magnetic stimulation units, disposable ureteroscopes, and laser platforms for stone disease and sexual health. Leveraging Taiwan's manufacturing expertise and clinical collaborations, LITEMED delivers cost-effective solutions to global markets. As a privately held commercial-stage company with 200-500 employees, it has established a presence in urology without disclosing total funding or valuation. LITEMED's growth prospects hinge on expanding its product pipeline and geographic reach, particularly in emerging markets. The company's ability to innovate in minimally invasive technologies positions it well in the competitive urology device space, though private status limits visibility into financials and near-term milestones.

Upcoming Catalysts (preview)

• Q3 2026New product launch or regulatory clearance for next-generation disposable ureteroscope70% success
• Q2 2026Expansion into new geographic markets (e.g., Southeast Asia or Europe) through distribution partnerships60% success
• Q4 2026Clinical study results or publication for magnetic stimulation therapy in male sexual health50% success